About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker RACC

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Nov 13, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Michael Cho735,5389.5%SCHEDULE 13G ↗
Nov 13, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Affinity Asset Advisors, LLC735,5389.5%SCHEDULE 13G ↗
Oct 28, 2026SCHEDULE 13G/A (amended)RACC
Research Alliance Corporation III
Bank of America Corp /DE/1,1890.0%SCHEDULE 13G/A ↗
Oct 7, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Daniel Mack1.10M14.1%SCHEDULE 13G ↗
Oct 7, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Wilmot B. Harkey1.10M14.1%SCHEDULE 13G ↗
Oct 7, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Nantahala Capital Management, LLC1.10M14.1%SCHEDULE 13G ↗
Sep 11, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Ms. Lillian Nordahl504,8916.5%SCHEDULE 13G ↗
Sep 11, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Dr. Jeffrey R. Jay, M.D.504,8916.5%SCHEDULE 13G ↗
Sep 11, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Great Point Partners, LLC504,8916.5%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Chen Yu500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
TCG Crossover Fund III, L.P.500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
TCG Crossover GP III, LLC500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Dmitry Balyasny500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Dames GP LLC500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Balyasny Asset Management Holdings LP500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Bam GP LLC500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Balyasny Asset Management L.P.500,0006.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Daniel Schneeberger650,0008.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
ADAR1 Capital Management, LLC650,0008.4%SCHEDULE 13G ↗
Aug 13, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Simon Basseyn500,0006.4%SCHEDULE 13G ↗
Aug 13, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Alex R. Rosen500,0006.4%SCHEDULE 13G ↗
Aug 13, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Spruce Street Capital LP500,0006.4%SCHEDULE 13G ↗
Aug 3, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Bank of America Corp /DE/503,9146.5%SCHEDULE 13G ↗
Jul 28, 2026SCHEDULE 13D/A (amended)RACC
Research Alliance Corporation III
Matthew Hammond1.52M16.9%SCHEDULE 13D/A ↗
Jul 28, 2026SCHEDULE 13D/A (amended)RACC
Research Alliance Corporation III
Research Alliance Holdings III LLC1.52M16.9%SCHEDULE 13D/A ↗
May 29, 2026SCHEDULE 13DRACC
Research Alliance Corporation III
Matthew Hammond1.52M14.7%SCHEDULE 13D ↗
May 29, 2026SCHEDULE 13DRACC
Research Alliance Corporation III
Research Alliance Holdings III LLC1.52M14.7%SCHEDULE 13D ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Ortav Yehudai500,0005.5%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Trails Edge Biotechnology Master Fund, LP500,0005.5%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Trails Edge Capital Partners, LP500,0005.5%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Mark N. Lampert500,0006.4%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
BVF Inc/Il500,0006.4%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
BVF Partners L P/Il500,0006.4%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
BVF GP Holdings LLC459,5905.9%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
BVF Partners OS Ltd.33,1160.4%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Biotechnology Value Trading Fund OS LP33,1160.4%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
BVF II GP LLC197,6672.5%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Biotechnology Value Fund II LP197,6672.5%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
BVF I GP LLC261,9233.4%SCHEDULE 13G ↗
May 29, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Biotechnology Value Fund L P261,9233.4%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Michael Kramarz500,0005.5%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Robert Egen Atkinson500,0005.5%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Commodore Capital Master LP500,0005.5%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Commodore Capital LP500,0005.5%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Perceptive Life Sciences Master Fund, Ltd.750,0008.2%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Joseph Edelman750,0008.2%SCHEDULE 13G ↗
May 28, 2026SCHEDULE 13GRACC
Research Alliance Corporation III
Perceptive Advisors LLC750,0008.2%SCHEDULE 13G ↗

47 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 10:30 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances